Quality of anticoagulation with warfarin in rural Chhattisgarh, India

被引:6
|
作者
Chebrolu, Puja [1 ]
Patil, Sushil [4 ]
Laux, Timothy S. [3 ]
Al-Hammadi, Noor [2 ]
Jain, Yogesh [4 ]
Gage, Brian [1 ]
机构
[1] Washington Univ, Dept Med, St Louis, MO USA
[2] Washington Univ, Div Biostat, St Louis, MO 63110 USA
[3] Columbia Univ, Med Ctr, Dept Hosp Med, New York, NY USA
[4] Jan Swasthya Sahyog, Ganiyari, Chhattisgarh, India
关键词
INTERNATIONAL NORMALIZED RATIO; ATRIAL-FIBRILLATION; ORAL ANTICOAGULANT; STROKE; THERAPY; METAANALYSIS; DABIGATRAN; INTENSITY; EFFICACY; OUTCOMES;
D O I
10.4103/ijmr.IJMR_1201_18
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: In most of rural India, warfarin is the only oral anticoagulant available. Among patients taking warfarin, there is a strong association between poor control of the international normalized ratio (INR) and adverse events. This study was aimed to quantify INR control in a secondary healthcare system in rural Chhattisgarh, India. Methods: The INR data were retrospectively obtained from all patients taking warfarin during 2014-2016 at a secondary healthcare system in rural Chhattisgarh, India. Patients attending the clinic had their INR checked at the hospital laboratory and their warfarin dose adjusted by a physician on the same day. The time in therapeutic range (TTR) was calculated for patients who had at least two INR visits. Results: The 249 patients had 2839 INR visits. Their median age was 46 yr, and the median body mass index was 17.7 kg/m[2]. They lived a median distance of 78 km (2-3 h of travel) from the hospital. The median INR was 1.7 for a target INR of 2.0-3.0 (n=221) and 2.1 for a target of 2.5-3.5 (n=28). The median TTR was 13.0 per cent, and INR was subtherapeutic 66.0 per cent of the time. Distance from the hospital was not correlated with TTR. Interpretation & conclusions: INR values were subtherapeutic two-thirds of the time, and TTR values were poor regardless of distance from the health centre. Future studies should be done to identify interventions to improve INR control.
引用
收藏
页码:303 / 307
页数:5
相关论文
共 50 条
  • [1] Quality of Anticoagulation With Warfarin at a Tertiary Hospital in Botswana
    Mwita, Julius C.
    Francis, Joel M.
    Oyekunle, Anthony A.
    Gaenamong, Marea
    Goepamang, Monkgogi
    Magafu, Mgaywa G. M. D.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (04) : 596 - 601
  • [2] Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting
    Han, Seol Young
    Palmeri, Sebastian T.
    Broderick, Samuel H.
    Hasselblad, Vic
    Rendall, Dave
    Stevens, Scott
    Tenaglia, Alan
    Velazquez, Eric
    Whellan, David
    Wagner, Galen
    Heitner, John F.
    JOURNAL OF ELECTROCARDIOLOGY, 2013, 46 (01) : 45 - 50
  • [3] The effect of the amiodarone-warfarin interaction on anticoagulation quality in a single, high-quality anticoagulation center
    White, Ryan D.
    Riggs, Kyle W.
    Ege, Ed J.
    Petroski, Gregory F.
    Koerber, Scott M.
    Flaker, Greg
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (02) : 147 - 150
  • [4] Warfarin treatment quality is consistently high in both anticoagulation clinics and primary care setting in Sweden
    Bjorck, Fredrik
    Sanden, Per
    Renlund, Henrik
    Svensson, Peter J.
    Sjalander, Anders
    THROMBOSIS RESEARCH, 2015, 136 (02) : 216 - 220
  • [5] Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)
    Lee, Tetz C.
    Qian, Min
    Lip, Gregory Y. H.
    Di Tullio, Marco R.
    Graham, Susan
    Mann, Douglas L.
    Nakanishi, Koki
    Teerlink, John R.
    Freudenberger, Ronald S.
    Sacco, Ralph L.
    Mohr, J. P.
    Labovitz, Arthur J.
    Ponikowski, Piotr
    Lok, Dirk J.
    Estol, Conrado
    Anker, Stefan D.
    Pullicino, Patrick M.
    Buchsbaum, Richard
    Levin, Bruce
    Thompson, John L. P.
    Homma, Shunichi
    Ye, Siqin
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (05) : 821 - 827
  • [6] Improving Anticoagulation Measurement Novel Warfarin Composite Measure
    Razouki, Zayd
    Burgess, James F., Jr.
    Ozonoff, Al
    Zhao, Shibei
    Berlowitz, Dan
    Rose, Adam J.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2015, 8 (06): : 600 - 607
  • [7] Quality of warfarin control in atrial fibrillation patients in South East Queensland, Australia
    Bernaitis, N.
    Badrick, T.
    Davey, A. K.
    Anoopkumar-Dukie, S.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (08) : 925 - 931
  • [8] Effect of a Warfarin Adherence Aid on Anticoagulation Control in an Inner-City Anticoagulation Clinic Population
    Nochowitz, Beth
    Shapiro, Nancy L.
    Nutescu, Edith A.
    Cavallari, Larisa H.
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (7-8) : 1165 - 1172
  • [9] Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries An Analysis of Patients Receiving Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
    Van Spall, Harriette G. C.
    Wallentin, Lars
    Yusuf, Salim
    Eikelboom, John W.
    Nieuwlaat, Robby
    Yang, Sean
    Kabali, Conrad
    Reilly, Paul A.
    Ezekowitz, Michael D.
    Connolly, Stuart J.
    CIRCULATION, 2012, 126 (19) : 2309 - 2316
  • [10] Assessment of the quality of anticoagulation management with warfarin in a tertiary care center
    Albabtain, Monirah A.
    Alharthi, Maha M.
    Dagriri, Khalid
    Arafat, Amr A.
    Ayrout, Esraa
    Alhebaishi, Yahya
    AlFagih, Ahmed
    SAUDI MEDICAL JOURNAL, 2020, 41 (11) : 1245 - 1251